📰 Endothelial Dysfunction News
Endothelial Dysfunction News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Endothelial Dysfunction. Real-time updates on events, politics, business and more.
May 2, 2024
Recently, scientists from Columbia University revealed that experiencing intense anger could damage lining of the person's blood vessels, known as endothelium, eventually increasing the risk of heart disease.
November 2, 2023
TOULOUSE, France & LAKELAND, Mich., November 02, 2023--ABIONYX Pharma, (FR0012616852 - ABNX - PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies based on the world's only recombinant human apoA-1, today announced the full results of the RACERS Phase 2 clinical trial of CER-001, an apoA-1-based therapy for the treatment of sepsis, in a late-breaking clinical trial poster presentation at the American Society of Nephrolog...
May 3, 2023
The wide-ranging research aims to unlock the potential of angiotensin II type 2 receptor agonists - News - PharmaTimes
March 13, 2023
Some types of foods are better than others for circulation. Find out what to look for, as part of your healthy lifestyle.
March 1, 2023
Some types of foods are better than others for circulation. Find out what to look for, as part of your healthy lifestyle.
January 27, 2023
Tree nuts have been part of the human diet since ancient times. Consuming these small yet nutrition-packed superfoods is encouraged and even promoted in many dietary guidelines worldwide because [...]
October 19, 2022
Researchers discussed the pathophysiological mechanisms of endothelial dysfunction associated with severe coronavirus disease 2019 (COVID-19) and commented on the potential therapeutic strategies to treat endothelial damage and coagulopathy related to COVID-19.
May 21, 2022
Blueberries can lower the risk of heart disease in post-menopausal women with high blood pressure.
April 14, 2022
A multi-centre study led by the University Hospital Hamburg-Eppendorf (UKE) is evaluating one of the first personalised approaches for moderate to sever...
April 11, 2022
A multi-center study led by UKE is evaluating one of the first personalized approaches for moderate to severe COVID-19 patients.The innovative biomarkers bio-ADM and DPP3 are guiding the enrollment of